NCT00380445View on ClinicalTrials.gov

Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Vildagliptin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Novartis Investigative Site, Investigative Centers

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY